The impact of ACE2 genetic polymorphisms (rs2106809 and rs2074192) on gender susceptibility to COVID-19 infection and recovery: A systematic review
Open Access
- 1 July 2021
- journal article
- review article
- Published by Department of Chemistry and Biochemistry, Al-Nahrain University in Baghdad Journal of Biochemistry and Applied Biological Sciences
- Vol. 2 (03), 167-180
- https://doi.org/10.47419/bjbabs.v2i03.53
Abstract
Background: Epidemiological studies revealed there is a difference in susceptibility to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) because of differences in gender with age and males being more inflicted. There is a clear indication that deaths caused by coronavirus disease 2019 (COVID-19) in males appeared at a higher rate than females across 35 nations. The implication of associated disease-risk genes, involved in the susceptibility of COVID-19 such as the angiotensin-converting enzyme 2 (ACE2), has recently received considerable attention due to their role in severe injury of lung and mediated SARS-CoV-2 entry as a host receptor. Objectives: Herein, we aimed to systematically review how two main genetic polymorphisms of ACE2 (rs2106809 and rs2074192) can affect the gender susceptibility to SARS-CoV-2 infection. Methods: To conduct this systematic review, a literature search in PubMed, Google Scholar, ScienceDirect, and Nature was made for the period 2004 to 2020. We searched for the impact of ACE2 genetic polymorphisms (rs2106809 and rs2074192) on gender susceptibility. Results: We noticed that there was a differential genotype distribution between males and females in various global populations whereas mutant variants were common in males compared to wild-type variants among females, which may reflect differences in gender susceptibility to infection with SARS-CoV-2. Females are less susceptible to coronavirus as compare to males because of the expression of ACE2 receptor. It has a double role in favour of COVID-19 and against COVID-19. Conclusions: Male mortality is greater than female mortality, which might be attributed to the ACE2 deficiency in women. Epidemiological studies have shown that the differences in sex and age have different susceptibility to SARS-CoV-2 infection.Keywords
This publication has 42 references indexed in Scilit:
- Update on the Angiotensin Converting Enzyme 2-Angiotensin (1–7)-Mas Receptor Axis: Fetal Programing, Sex Differences, and Intracellular PathwaysFrontiers in Endocrinology, 2014
- The association between the angiotensin-converting enzyme-2 gene and blood pressure in a cohort study of adolescentsBMC Medical Genetics, 2013
- The Role of Androgens and Estrogens on Healthy Aging and LongevityThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2012
- Angiotensinergic Signaling in the Brain Mediates Metabolic Effects of Deoxycorticosterone (DOCA)-Salt in C57 MiceHypertension, 2011
- A scalable, fully automated process for construction of sequence-ready human exome targeted capture librariesGenome Biology, 2011
- Synergistic Expression of Angiotensin-Converting Enzyme (ACE) and ACE2 in Human Renal Tissue and Confounding Effects of Hypertension on the ACE to ACE2 RatioEndocrinology, 2007
- Identification of new human coronavirusesExpert Review of Anti-infective Therapy, 2007
- Age- and gender-related difference of ACE2 expression in rat lungLife Sciences, 2006
- A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injuryNature Medicine, 2005
- Angiotensin-converting enzyme 2 protects from severe acute lung failureNature, 2005